Health Care/Hospital APAC News & Press Release Distribution

Fosun Foundation's Second Batch of More Than 500,000 Pieces of Anti-epidemic Materials Arrives in Hong Kong Successively to Aid High-risk Groups and Grassroots Families

HONG KONG, March 10, 2022 /PRNewswire/ -- In the face of the severe fifth wave of epidemic inHong Kong, Fosun Foundation quickly launched the epidemic relief work of "Let's Work Hand in Hand and Combat the Epidemic Together" inHong Kong. After the first batch of 250,000 sets of COVID-19 rapid ant...

2022-03-10 14:25 2391

Fosun Foundation's Second Batch of More Than 500,000 Pieces of Anti-epidemic Materials Arrives in Hong Kong Successively to Aid High-risk Groups and Grassroots Families

Everlife acquires Research Instruments Group and other laboratory suppliers to boost presence in strategic life sciences and clinical diagnostics segments in South East Asia

SINGAPORE, March 10, 2022 /PRNewswire/ -- Everlife Holdings Pte Ltd ("Everlife"), a leading market access and distribution company inIndia and South East Asia, has announced the completion of its acquisition of Research Instruments Group ("RI"), a leading provider of scientific and laboratory in...

2022-03-10 12:00 3031

Nature Research Custom Media: SHAPING THE FUTURE OF OMICS FOR ALL

SHENZHEN, China, March 10, 2022 /PRNewswire/ -- Nature Research Custom Media published a feature story "Shaping the Future of Omics for All" about BGI Genomics, showcasing how the world-leading genome sequencing organization cultivates and leads the gene sequencing service industry and brings ...

2022-03-10 10:05 2172

Nature Research Custom Media: SHAPING THE FUTURE OF OMICS FOR ALL

Antengene Announces IND Approval in China for the Phase I Study of ATG-101 (PD-L1/4-1BB Bispecific Antibody) for the Treatment of Solid Tumors and Non-Hodgkin Lymphoma

- The novel bispecific antibody ATG-101 is Antengene's first in house developed molecule with global rights. - This approval in China marks the third regulatory clearance granted to ATG-101 globally. - Upon receiving clearances in Australia and the U.S. in 2021, the Phase I study of ATG-101 ...

2022-03-10 08:52 2134

Transcenta Presented Safety / Tolerability and Preliminary Anti-tumor Activity Data in Gastric and Pancreatic Cancers of TST001 Monotherapy from China Phase I Clinical Trial at the 2022 International Gastric Cancer Congress

SUZHOU, China, March 10, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that Transcenta has ...

2022-03-10 08:30 2929

Baxter launches Know your Score campaign, highlighting the importance of early screening to tackle the growing burden of kidney disease in Asia Pacific

MANILA, Philippines, March 10, 2022 /PRNewswire/ -- Baxter Asia Pacific (Baxter), a global leader in dialysis care, has launched theKnow Your Score campaign across Asia Pacific (APAC) on World Kidney Day. Know Your Score aims to educate the public on their kidney score[1] as a gauge of thei...

2022-03-10 07:00 1401

Baxter launches Know your Score campaign, highlighting the importance of early screening to tackle the growing burden of kidney disease in Asia Pacific

JAKARTA, Indonesia, March 10, 2022 /PRNewswire/ -- Baxter Asia Pacific (Baxter), a global leader in dialysis care, has launched theKnow Your Score campaign across Asia Pacific (APAC) on World Kidney Day. Know Your Score aims to educate the public on their kidney score[1] as a gauge of their...

2022-03-10 07:00 1345

Baxter launches Know your Score campaign, highlighting the importance of early screening to tackle the growing burden of kidney disease in Asia Pacific

SINGAPORE, March 10, 2022 /PRNewswire/ -- Baxter Asia Pacific (Baxter), a global leader in dialysis care, has launched theKnow Your Score campaign across Asia Pacific (APAC) on World Kidney Day. Know Your Score aims to educate the public on their kidney score[1] as a gauge of their kidney health...

2022-03-10 07:00 1271

Know your Score campaign, highlighting the importance of early screening to tackle the growing burden of kidney disease in Malaysia

KUALA LUMPUR, Malaysia, March 10, 2022 /PRNewswire/ -- Baxter Malaysia, a global leader in dialysis care, has launched theKnow Your Score campaign across Asia Pacific (APAC) on World Kidney Day. Know Your Score aims to educate the public on their kidney score[1] as a gauge of their kidney health...

2022-03-10 07:00 5093

Baxter launches Know your Score campaign, highlighting the importance of early screening to tackle the growing burden of kidney disease in Asia Pacific

SINGAPORE, March 10, 2022 /PRNewswire/ -- Baxter Asia Pacific (Baxter), a global leader in dialysis care, has launched theKnow Your Score campaign across Asia Pacific (APAC) on World Kidney Day. Know Your Score aims to educate the public on their kidney score[1] as a gauge of their kidney health...

2022-03-10 07:00 1290

Baxter launches Know your Score campaign, highlighting the importance of early screening to tackle the growing burden of kidney disease in Asia Pacific

BANGKOK, March 10, 2022 /PRNewswire/ -- Baxter Asia Pacific (Baxter), a global leader in dialysis care, has launched theKnow Your Score campaign across Asia Pacific (APAC) on World Kidney Day. Know Your Score aims to educate the public on their kidney score[1] as a gauge of their kidney hea...

2022-03-10 07:00 1373

Baxter launches Know your Score campaign, highlighting the importance of early screening to tackle the growing burden of kidney disease in Asia Pacific

HO CHI MINH CITY, Vietnam, March 10, 2022 /PRNewswire/ -- Baxter Asia Pacific (Baxter), a global leader in dialysis care, has launched theKnow Your Score campaign across Asia Pacific (APAC) on World Kidney Day. Know Your Score aims to educate the public on their kidney score[1] as a gauge o...

2022-03-10 07:00 1627

Insilico Medicine enters research collaboration with the University of Zurich to apply Insilico's generative Artificial Intelligence platform for the discovery of potential therapeutics for Cystinosis

- Cystinosis is a rare genetic disease affecting 1 in 100,000-200,000 live births and poses a lifelong risk to those affected. Cystinosis slowly destroys the body's organs including the kidneys, eyes, thyroid, muscles, liver, pancreas, gonads, and brain. - There are currently no curative treatme...

2022-03-10 00:57 2074

Insilico Medicine enters research collaboration with the University of Zurich to apply Insilico's generative Artificial Intelligence platform for the discovery of potential therapeutics for Cystinosis

Sofwave Medical LTD reports financial results for the full year 2021 with accelerated growth in revenues and gross margin

Revenue increased in 2021 to $21.8M vs. $4.3M in 2020 2021 second-half revenue increased to $11.7M vs. $3.5M in the second half of 2020 Record Q4 2021 revenues of $8.9M Revenue from pulses for the full year 2021 increased to $2.6M TEL AVIV, Israel, March 9, 2022 /PRNewswire/ -- Mr. Lou Scafuri,...

2022-03-09 23:20 1814

Databricks Introduces Lakehouse for the Healthcare and Life Sciences Industries to Drive Transformation Across Healthcare Ecosystem

As the industry begins to embrace the power of AI, the lakehouse brings patient, research, and operational data together at scale to deliver new innovations in research and care SAN FRANCISCO, March 9, 2022 /PRNewswire/ -- Databricks, the Data and AI company and pioneer of the data lakehouse par...

2022-03-09 22:00 1715

SOPHiA GENETICS HRD Solution Adopted in Asia Pacific

BOSTON, LAUSANNE, Switzerland and TAIPEI CITY, Taiwan, March 9, 2022 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH) today announced that SOFIVA GENOMICS, which is one of the largest genetic testing companies inTaiwan aiming to provide genetic testing to clinicians, is the first institution inAsia...

2022-03-09 21:57 1924

NCCN Expands Resources for Treating Rare Cancer Types

The National Comprehensive Cancer Network publishes two new NCCN Guidelines for Malignant Peritoneal Mesothelioma and for Ampullary Adenocarcinoma, to standardize treatment and improve outcomes for these rare tumor types; also reaches milestone expanding library of NCCN Chemotherapy Order Templat...

2022-03-09 21:56 1410

NCCN Expands Resources for Treating Rare Cancer Types

Kusum Healthcare recognized as one of Best Places to Work in Philippines for 2022

MANILA, Philippines, March 9, 2022 /PRNewswire/ -- Kusum Healthcare, a leading tech-driven pharmaceutical group, has been recently awarded the Best Place to Work certification inPhilippines for 2022. During the company assessment, 97% of employees recommended the organization illustrating the com...

2022-03-09 20:22 1592

Antengene Announces Five Upcoming Presentations at the 2022 American Association for Cancer Research Annual Meeting

* Posters Showcase Early-Stage Clinical and Preclinical Pipeline. * Focus on ATG-037, ATG-018, ATG-022, ATG-012 and ATG-008. SHANGHAI and HONG KONG, March 9, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, global biopharmaceutical company ...

2022-03-09 20:00 2084

Pudu Robotics Helps Hong Kong Combat Covid-19 Pandemic

The firm once again participates in the fight against the pandemic by donating robots that support contactless delivery and automatic disinfection SHENZHEN, China, March 9, 2022 /PRNewswire/ -- Pudu Robotics , the global leader in commercial service robots, has dona...

2022-03-09 20:00 2308